Clinical Trial Update: Immunotherapy of the Recent-onset Type 1 Diabetes in Adolescents With Repeated Courses of Rituximab [Phase 2]

View source ↗

Summary

This update reports an ongoing Phase 2 clinical trial evaluating repeated courses of Rituximab as immunotherapy for adolescents with recent-onset type 1 diabete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Pirogov Russian National Research Medical University | Conditions: Diabetes Mellitus, Type 1 | Phase 2 | Status: RECRUITING